SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-050851
Filing Date
2021-10-14
Accepted
2021-10-14 16:20:02
Documents
68
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrix-10q_20210831.htm   iXBRL 10-Q 3292948
2 EX-10.1 nrix-ex101_27.htm EX-10.1 23036
3 EX-10.2 nrix-ex102_26.htm EX-10.2 290325
4 EX-31.1 nrix-ex311_8.htm EX-31.1 19981
5 EX-31.2 nrix-ex312_7.htm EX-31.2 19971
6 EX-32.1 nrix-ex321_6.htm EX-32.1 15645
7 GRAPHIC gfjxhd4gmpap000001.jpg GRAPHIC 6995
  Complete submission text file 0001564590-21-050851.txt   9662950

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nrix-20210831.xsd EX-101.SCH 51586
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nrix-20210831_cal.xml EX-101.CAL 43989
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrix-20210831_def.xml EX-101.DEF 162024
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrix-20210831_lab.xml EX-101.LAB 410929
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrix-20210831_pre.xml EX-101.PRE 299323
13 EXTRACTED XBRL INSTANCE DOCUMENT nrix-10q_20210831_htm.xml XML 1534058
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-39398 | Film No.: 211323551
SIC: 2834 Pharmaceutical Preparations